Niepubliczny Zaklad Opieki Zdrowotnej Biogenes Sp. z o.o
- Address
- lock Available on a paid plan
Niepubliczny Zaklad Opieki Zdrowotnej Biogenes Sp. z o.o - Autoimmune and Rheumatologic Disease Research Center
Biogenes is a specialized clinical research facility focused on advancing therapeutic options for patients with autoimmune and rheumatologic conditions. The center demonstrates particular expertise in conducting phase 3 clinical trials evaluating novel biologic therapies and biosimilars for inflammatory diseases affecting joints, skin, and connective tissues.
- Psoriatic Arthritis - Long-term safety studies and comparative efficacy trials of bimekizumab versus other biologics
- Axial Spondyloarthritis - Extended treatment evaluation of advanced biological therapies
- Rheumatoid Arthritis - Subcutaneous biologic treatment trials for moderate to severe disease
- Systemic Sclerosis - Novel immunomodulatory therapies targeting skin sclerosis
The facility's research portfolio emphasizes long-term safety monitoring and comparative effectiveness studies, with significant experience in administering and evaluating subcutaneous biological agents. Their involvement in multiple extension studies demonstrates commitment to understanding the sustained efficacy and safety profiles of emerging therapies across the spectrum of inflammatory rheumatic diseases.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
- 1Argenx1active
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1UCB Biopharma3trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Niepubliczny Zaklad Opieki Zdrowotnej Biogenes Sp. z o.o
lock Showing 1 of 7 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of Bimekizumab Versus Risankizumab in Adults with Active Psoriatic Arthritis: A Multicenter, Randomized, Double-Blind Study | UCB Biopharma | Phase III | Not Recruiting | Dec 2024 | May 2026 |
IMP list
lock Showing 1 of 12 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Bimekizumab | 3 | Unknown | 2019-11-21 | 2024-12-18 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.